Sign up to save your podcasts
Or
Share Looking Ahead in Complement-Mediated Kidney Diseases: What Clinical Questions Do Current Trials Aim to Answer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Looking Ahead in Complement-Mediated Kidney Diseases: What Clinical Questions Do Current Trials Aim to Answer
Did you know that, if left untreated, between 30% and 50% and up to 30% of patients with C3G and IgAN, respectively, will progress to end-stage kidney disease in 10 years? Credit available for this activity expires: 5/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/992405?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape
4.3
2323 ratings
Did you know that, if left untreated, between 30% and 50% and up to 30% of patients with C3G and IgAN, respectively, will progress to end-stage kidney disease in 10 years? Credit available for this activity expires: 5/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/992405?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current CME
View all
The Bob Harrington Show
13 Listeners
NEJM This Week
316 Listeners
Diabetes Core Update
107 Listeners
JACC This Week
171 Listeners
This Week in Cardiology
866 Listeners
JAMA Clinical Reviews
498 Listeners
AFP: American Family Physician Podcast
687 Listeners
One-on-One with Eric Topol
18 Listeners
Mayo Clinic Talks
278 Listeners
Frankly Speaking About Family Medicine
256 Listeners
The Curbsiders Internal Medicine Podcast
3,321 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
135 Listeners
Core IM | Internal Medicine Podcast
1,101 Listeners
The Peter Attia Drive
8,002 Listeners
Annals On Call Podcast
194 Listeners
Medicine and the Machine
60 Listeners
Keeping Current
8 Listeners
Cardionerds: A Cardiology Podcast
428 Listeners
The Cribsiders
313 Listeners